These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 26471690)

  • 1. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
    Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
    J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying Amide Proton Transfer MR Imaging to Hybrid Brain PET/MR: Concordance with Gadolinium Enhancement and Added Value to [
    Sun H; Xin J; Zhou J; Lu Z; Guo Q
    Mol Imaging Biol; 2018 Jun; 20(3):473-481. PubMed ID: 29063304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
    Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
    Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
    Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
    Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
    Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
    Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study.
    Nensa F; Tezgah E; Poeppel TD; Jensen CJ; Schelhorn J; Köhler J; Heusch P; Bruder O; Schlosser T; Nassenstein K
    J Nucl Med; 2015 Feb; 56(2):255-60. PubMed ID: 25552667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
    Coulam CH; Chan FP; Li KC
    AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging children suffering from lymphoma: an evaluation of different
    Kirchner J; Deuschl C; Schweiger B; Herrmann K; Forsting M; Buchbender C; Antoch G; Umutlu L
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1742-1750. PubMed ID: 28534182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performing clinical 18F-FDG-PET/MRI of the mediastinum optimising a dedicated, patient-friendly protocol.
    Peerlings J; Paulis L; Mitea C; Bakers F; Berbée M; Wierts R; Vöö S; Wildberger J; Hoffmann A; Lambin P; Mottaghy F
    Nucl Med Commun; 2019 Aug; 40(8):815-826. PubMed ID: 31169592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging.
    Soyer P; de Givry SC; Gueye C; Lenormand S; Somveille E; Scherrer A
    AJR Am J Roentgenol; 1996 May; 166(5):1115-21. PubMed ID: 8615254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous
    Pyatigorskaya N; De Laroche R; Bera G; Giron A; Bertolus C; Herve G; Chambenois E; Bergeret S; Dormont D; Amor-Sahli M; Kas A
    AJNR Am J Neuroradiol; 2020 Oct; 41(10):1888-1896. PubMed ID: 32972956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.
    Muehe AM; Theruvath AJ; Lai L; Aghighi M; Quon A; Holdsworth SJ; Wang J; Luna-Fineman S; Marina N; Advani R; Rosenberg J; Daldrup-Link HE
    Mol Imaging Biol; 2018 Apr; 20(2):324-335. PubMed ID: 28721605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-breath-hold fast spin-echo versus breath-hold fast spin-echo and spoiled gradient-recalled echo MR imaging in the detection of hepatic tumors: correlation with surgical findings.
    Soyer P; Gouhiri M; Rondeau Y; Spelle L; Mosnier H; Scherrer A
    AJR Am J Roentgenol; 1997 May; 168(5):1199-204. PubMed ID: 9129411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
    Watanabe H; Kanematsu M; Kondo H; Kako N; Yamamoto N; Yamada T; Goshima S; Hoshi H; Bae KT
    J Magn Reson Imaging; 2010 May; 31(5):1151-6. PubMed ID: 20432351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
    Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H
    Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.